The much-anticipated guideline is now available for RQA members.
More information
Mind the gap - connected by quality. 4th - 6th November 2026, London.
More information
RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationProfessor Jacob George has started as MHRA’s first ever Chief Medical and Scientific Officer, bringing senior clinical and scientific leadership to the regulator.
The MHRA reflects on key med-tech achievements and regulatory milestones from 2025.
EDQM reflects on a year of major change — strengthening partnerships, modernising the European Pharmacopoeia and reaffirming its public-health mission.
EMA has launched a concept paper to modernise GMP Annex 3 for radiopharmaceuticals, reflecting major scientific and regulatory changes since 2008.
EMA’s Management Board welcomed political agreement on new EU pharma legislation and set out priorities and investment plans for 2026 and beyond.
The FDA has updated guidance on how Real-World Evidence can support medical device approvals and post-market decisions.
The FDA has published draft guidance clarifying what investigators must report, and when, during clinical research involving investigational drugs and devices.
The MHRA is asking the public, clinicians and industry to help shape future rules for AI in healthcare. Link to press release.
The FDA has issued final guidance setting out what sponsors and research sites should expect during BIMO inspections, and how to manage inspection communications and records requests.
The MHRA is inviting views on how AI used in healthcare should be regulated, as part of work to shape a new UK framework for AI medical devices.